Examination of optimized protocols for pCASL: Sensitivity to macrovascular contamination, flow dispersion, and prolonged arterial transit time by Zhang, Logan X. et al.
Magn Reson Med. 2021;00:1–12.    | 1wileyonlinelibrary.com/journal/mrm
Received: 18 December 2020 | Revised: 19 March 2021 | Accepted: 23 April 2021
DOI: 10.1002/mrm.28839  
F U L L  P A P E R
Examination of optimized protocols for pCASL: Sensitivity to 
macrovascular contamination, flow dispersion, and prolonged 
arterial transit time
Logan X. Zhang1  |   Joseph G. Woods2,3  |   Thomas W. Okell2  |    
Michael A. Chappell1,2,4,5,6
1Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom
2Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom
3Department of Radiology, University of California San Diego, San Diego, California, USA
4Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United Kingdom
5Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom
6Nottingham Biomedical Research Centre, Queen’s Medical Centre, University of Nottingham, Nottingham, United Kingdom
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2021 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
Correspondence
Michael A. Chappell, Beacon Hub Offices, 
A Floor, School of Medicine, University of 
Nottingham, Nottingham NG7 2UH, UK.
Email: Michael.Chappell@nottingham.ac.uk
Funding information
Wellcome Centre for Integrative 
Neuroimaging, Grant/Award Number: 
203139/Z/16/Z; Wellcome Trust, 
Grant/Award Number: 220204/Z/20/Z; 
Engineering and Physical Sciences 
Research Council, Grant/Award Number: 
EP/L016052/1 and EP/P012361/1; Royal 
Academy of Engineering, Grant/Award 
Number: RF/132
Purpose: Previously, multi- post- labeling delays (PLD) pseudo- continuous arterial 
spin labeling (pCASL) protocols have been optimized for the estimation accuracy 
of the cerebral blood flow (CBF) with/without the arterial transit time (ATT) under 
a standard kinetic model and a normal ATT range. This study aims to examine the 
estimation errors of these protocols under the effects of macrovascular contamination, 
flow dispersion, and prolonged arrival times, all of which might differ substantially 
in elderly or pathological groups.
Methods: Simulated data for four protocols with varying degrees of arterial blood 
volume (aBV), flow dispersion, and ATTs were fitted with different kinetic models, 
both with and without explicit correction for macrovascular signal contamination 
(MVC), to obtain CBF and ATT estimates. Sensitivity to MVC was defined and 
calculated when aBV > 0.5%. A previously acquired dataset was retrospectively 
analyzed to compare with simulation.
Results: All protocols showed underestimation of CBF and ATT in the prolonged 
ATT range. With MVC, the protocol optimized for CBF only (CBFopt) had the 
lowest sensitivity value to MVC, 33.47% and 60.21% error per 1% aBV in simulation 
and in vivo, respectively, among multi- PLD protocols. All multi- PLD protocols 
showed a significant decrease in estimation error when an extended kinetic model 
was used. Increasing flow dispersion at short ATTs caused increasing CBF and ATT 
overestimation in all protocols.
Conclusion: CBFopt was the least sensitive protocol to prolonged ATT and MVC 
for CBF estimation while maintaining reasonably good performance in estimating 
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1 |  INTRODUCTION
Arterial spin labeling (ASL) is gaining popularity for its 
inherently non- invasive ability to quantify brain perfusion, 
that is, regional cerebral blood flow (CBF).1 ASL image ac-
quisition adopts a label- control approach. In the label image, 
arterial- blood water spins are labeled by inversion,2 followed 
by one or multiple post- labeling delays (PLD) to allow blood 
to perfuse the target tissue before image readout. The same 
procedure is administered in the control image but without 
inversion of the spins. An ASL image is obtained by sub-
tracting the label image from the control image. Perfusion 
quantification using a single PLD is the general recommen-
dation of the community for clinical applications,3 due to its 
robustness to arterial transit time (ATT) and relatively sim-
ple implementation. However, there is a trade- off between 
the recommended long PLD, which ensures a more complete 
arrival of blood into long ATT regions, and ASL signal loss 
due to T1 relaxation. Therefore, there has been increasing 
interest in the greater accuracy available from multi- PLD 
ASL.4 In multi- PLD ASL, a series of paired label- control 
images can be acquired by incrementing the PLD or by use 
of a Look- Locker acquisition scheme.5 Signals from dif-
ferent time points are then fit with a tracer kinetic model 
depicting the dynamic concentration of the labeled blood 
water,6 enabling simultaneous quantification of CBF and 
other parameters, such as ATT.
Recently, a general framework was proposed by Woods 
et al for optimizing multi- PLD sampling protocols.7 This 
framework yielded two optimized multi- PLD protocols: 
CBF- ATTopt and CBFopt, which were optimized for com-
bined CBF and ATT estimation and CBF estimation only, 
respectively. Both optimized protocols achieved better pa-
rameter estimation performance than the more commonly 
used evenly spaced multi- PLD and single- PLD protocols.7 
However, as multi- PLD ASL tends to use some short PLDs, 
when labeled blood may not have reached the target tissue but 
remains in the major arteries, artifacts caused by macrovascu-
lar signal contamination (MVC) might arise.8 Furthermore, 
flow dispersion due to blood traversing the vascular branches 
and cardiac pulsation will compromise the idealized arte-
rial input function (AIF) in the kinetic model used in this 
framework.9 The effects of macrovascular contamination and 
flow dispersion might be more prominent in the presence of 
prolonged ATTs seen in cerebrovascular disease10 and deep 
white matter.11
In this study, we tested the performance for CBF and 
ATT estimation of the previously proposed protocols, 
CBF- ATTopt and CBFopt, along with a reference multi- 
PLD protocol and a single- PLD protocol, under the effects 
of MVC and dispersion over a prolonged ATT range (PAR), 
using both simulated and in vivo data. We examined CBF 
and ATT estimation errors across a range of arterial blood 
volumes (aBVs) to investigate the sensitivity to MVC of 
each protocol, while also comparing the results with an 
extended kinetic model that explicitly accounts for MVC 
effects. Furthermore, estimation errors of each protocol 
across different levels of dispersion, as well as over a PAR, 
were also examined.
2 |  METHODS
2.1 | Kinetic modeling
The kinetic model used in this work was based on the general 
kinetic model proposed by Buxton et al6 incorporating a mac-
rovascular compartment8 and a Gamma dispersion kernel.12 
In the general kinetic model, the ASL difference signal of the 
tissue compartment ΔMt (t) can be expressed by:
where M0B is the equilibrium magnetization of arterial blood 
and f  is the CBF in mlblood∕mltissue∕s. c (t), r (t), and m (t) de-
note the delivery function, residue function, and magnetization 
relaxation function, respectively. The ∗ denotes convolution op-
eration. For pseudo- continuous ASL (pCASL), these functions 
take the form of:










r (t) = e− ft∕
m (t) = e− t∕T1t ,
ATT. Explicitly including a macrovascular component in the kinetic model was 
shown to be a feasible approach in controlling for MVC.
K E Y W O R D S
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where  is the labeling efficiency, Δt is the ATT of tissue,  is 
the label duration, T1b and T1t are the longitudinal relaxation 
constants of arterial blood and tissue, respectively, and  is the 
blood- tissue partition coefficient of water.
The form of the difference signal of the macrovascular 
compartment8 is related to the delivery function c (t) but has 
its own transit time Δta:
where aBV is the arterial blood volume fraction in per-
centage. The total signal in a voxel is the sum of its tis-
sue compartment and macrovascular compartment, that is, 
ΔM (t) = ΔMt (t) + ΔMa (t).
Flow dispersion can be accounted for by convolving the 
delivery function c (t) with a dispersion kernel k (t) to change 
its shape. Therefore,
Here, we chose a Gamma dispersion kernel for its phys-
iologically plausible shape and relatively low computational 
complexity12:
where Γ (x) is the Gamma function, and s, p depicts the “sharp-
ness” and time- to- peak characteristics of the dispersion kernel. 
The lower the value of s, the less sharp the Gamma kernel is, 
and the higher degree of dispersion the kernel adds to the sig-
nal. In this study, we used the same dispersion parameters for 
both tissue and macrovascular components.
By switching whether dispersion or macrovascular con-
tamination is included, four types of signals were simulated: 
no dispersion no macrovascular contamination (D- M- ), no 
dispersion with macrovascular contamination (D- M+), with 
dispersion no macrovascular contamination (D+M- ), and 
with dispersion with macrovascular contamination (D+M+).
2.2 | Simulation experiments
Four different PLD protocols from Woods et al were inves-
tigated: single- PLD, reference multi- PLD, CBF- ATTopt, 
and CBFopt.7 These protocols were optimized for CBF and/
or ATT accuracy for an ATT range of 0.5 s to 1.8 s in the 
absence of dispersion and macrovascular signal. Table 1 lists 
the PLDs and number of averages for each protocol obtained 
by optimization. For each protocol, pCASL signals were 
simulated in MATLAB (The Mathworks, Natick, MA) using 
the four models in the previous section. Two factors were 
varied in simulation: ATTs from 0.5 s to 3.0 s with 0.05 s 
interval, which includes ATT values much longer than those 
which had been optimized for, and an aBV range from 0 to 
2% with 0.05% interval. To test the effects of flow dispersion, 
simulations were performed three times based on different 
values of s (and a constant p0 = 0.17s) in the Gamma kernel: 
s0 = 1∕0.13 s
−1, s0∕2, and s0∕4, each with a higher degree of 
flow dispersion. Supporting Information Figure S1, which is 
available online, illustrates the effect of different dispersion 
kernels on both tissue and macrovascular signals. Gaussian 
white noise was then added to all signals, with its SD defined 
by the maximum signal intensity sampled across all PLDs 
in a typical condition (ATT = 1.4 s, aBV = 0.2%) over a 
signal- to- noise ratio (SNR) of 9.37 under common MR ac-
quisition environment,13 that is, SDnoise = ΔMsamp_max∕SNR. 
Each condition was repeated for 2000 times. See Table 2 for 
all simulation parameters. For the purposes of simplification 
in this study, macrovascular ATT was fixed relative to tissue 
ATT by 0.5 s, this implicitly assumes that the mechanism 
that prolongs the ATT (eg, pathology in the feeding arteries) 
affects both the macrovascular and tissue blood supply by the 
same amount, but the reality in vivo may be more complex 
than this in practice.
Noisy signals for each protocol were then fit with dif-










⋅aBV Δta < t<Δta+𝜏
0 Δt+𝜏 < t
c� (t) = c (t) ∗ k (t) .
k (t) =
s1+ sp
Γ (1 + sp)
tspe− st
T A B L E  1  Protocol timings from Woods et al7
Protocol Post- labeling delays (s) PLDs (N) Averages (N)
Single- PLD 1.8 1 33
Reference multi- PLD 0.25, 0.5, 0.75, 1, 1.25, 1.5 6 7
CBF- ATTopt 0.2, 0.2, 0.225, 0.3, 0.375, 0.45, 0.5, 0.55, 0.6, 0.6, 0.625, 0.625, 0.65, 0.65, 
0.675, 0.675, 0.7, 0.7, 0.7, 0.7, 1.25, 1.275, 1.3, 1.35, 1.375, 1.4, 1.425, 1.425, 
1.475, 1.5, 1.675, 1.75, 1.8, 1.825, 1.85, 1.875, 1.9, 1.925, 1.95, 1.975
40 1
CBFopt 0.2, 0.7, 0.825, 1, 1.125, 1.25, 1.325, 1.4, 1.475, 1.55, 1.625, 1.675, 1.7, 1.725, 
1.75, 1.775, 1.8, 1.825, 1.85, 1.85, 1.875, 1.9, 1.925, 1.925, 1.95, 1.975, 1.975, 
2, 2.025, 2.025, 2.05, 2.075, 2.075
34 1
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multi- PLD protocols) estimates and errors using the BASIL 
toolkit from the Oxford Centre for Functional MRI of the 
Brain (FMRIB)'s software library (FSL),14 which uses a 
variational Bayesian inference method with estimation pri-
ors applied to each parameter. See Supporting Information 
Table S1 for a list of parameter priors used. All signals were 
fit with the general kinetic model (denoted gkm). D- M+, 
D+M- , and D+M+ data were also fitted with extended ki-
netic models by accounting for macrovascular contamination 
(denoted gkm+mvc), dispersion (denoted gkm+disp), or 
both (denoted gkm+disp+mvc). For the full list of models 
fit used, see Table 3. Apart from estimating for CBF and 
ATT in gkm, aBV  and Δta were estimated in gkm+mvc and 
gkm+disp+mvc, while s and p were estimated in gkm+disp 
and gkm+disp+mvc. Other parameters assumed the values 
of the priors in Supporting Information Table S1 when an 
estimation was not possible. For model fitting of the single- 
PLD protocol in simulation, we assumed an ATT of 1.25 s.7 
CBF and ATT estimation error using each model was cal-
culated by “(estimated value − ground truth value)/ground 
truth value * 100.” Results were compared both across mod-
els and across protocols. As a measure of each protocol’s 
sensitivity to macrovascular contamination, we calculated 
the slopes of the CBF and ATT estimation error line of best 
fit when aBV > 0.5% for D- M+ signals fitted with gkm and 
gkm+mvc.
2.3 | In vivo experiments
A dataset from seven healthy subjects (three female, 23- 
27 y old) from Woods et al was retrospectively analyzed 
to examine the consistency between the results of simula-
tions and in vivo acquisition.7 The pCASL imaging param-
eters were: 2D- EPI, five slices, voxel size = 3.4 × 3.4 × 5 
mm3, 1.4 s label duration, and flow crusher gradients with 
a cutoff velocity of 4 cm/s. A full list of imaging param-
eters and pre- processing methods can be found in Woods 
et al.7 Gray matter (GM) masks were obtained from the 
T1 structural image using the FAST tool from FSL.15 CBF 
and ATT estimates were obtained by fitting the data of 
each protocol with the four models. The estimates were 
then binned and averaged with 0.05 s ATT or 0.05% aBV 
interval across all subjects, so as to match the sampling 
points in simulation.
Another four sets of CBF and ATT estimates were ob-
tained by fitting the four models (gkm, gkm+disp, gk-
m+mvc, gkm+disp+mvc) to the combined data from all four 
protocols, giving an equal weighting to each protocol. Voxels 
were excluded if the CBF and ATT estimated by gkm from 
the combined data had SDs higher than 15 ml/100 g/min and 
1.0 s, respectively, and were restricted by the parameter range 
of interest (0.5 s < ATT < 3.0 s, 0.0 < aBV < 2.0%). These 
sets of estimates were used in place of ground- truth esti-
mates in calculating estimation errors of each protocol, since 
there was no independent gold- standard protocol or universal 
ground- truth for the in vivo data. For example, the CBF error 
of Reference Multi- PLD estimated by gkm with respect to 
the CBF estimated by gkm+mvc from the combined data was 
calculated by
Parameter Value
Cerebral blood flow ( f ) 60 ml/100 g/min
Blood- tissue partition coefficient of water () 0.9 ml/g
T1 of arterial blood (T
1b) 1.65 s
T1 of tissue (T
1t) 1.3 s
Labeling efficiency () 0.85
Label duration () 1.4 s
ATT of macrovascular compartment (Δta) Δt−0.5 s
Arterial blood volume (aBV) when varying tissue ATT 0.2%
Tissue ATT (Δt) when varying aBV 1.4 s
Sharpness of Gamma dispersion kernel (s
0
) 1/0.13 s−1
Time- to- peak of Gamma dispersion kernel (p
0
) 0.17 s
T A B L E  2  Parameters used for 
simulations
T A B L E  3  Models used for fitting each signal
Signal Models used for fitting
No dispersion no macrovascular 
contamination (D- M- )
general kinetic model (gkm)
No dispersion with macrovascular 
contamination (D- M+)
gkm, gkm+mvc
With dispersion no macrovascular 
contamination (D+M- )
gkm, gkm+disp
With dispersion with 
macrovascular contamination 
(D+M+)
gkm, gkm+mvc, gkm+disp, 
gkm+disp+mvc
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The resulting estimation errors were compared to the 
errors in the equivalent simulation study. For example, the 
above CBF estimation error was compared to the CBF error 
of Reference Multi- PLD using D- M+ signals fit by gkm. 
This allowed an assessment of whether differences seen 
using the gkm on real data when compared to using a more 
sophisticated model matched with the errors seen in simu-
lation when dispersion and/or macrovascular contamination 
were included in the signal.
Similar to the sensitivity to MVC measure obtained in 
simulation, slopes of CBF and ATT estimation errors fit with 
gkm and gkm+mvc (with respect to CBFcombined, gkm+mvc and 
ATTcombined, gkm+mvc) were generated by linear regression 
when aBV > 0.5%. All statistical tests were performed using 
two- sample t- tests (one- tailed, with Bonferroni correction for 
multiple comparisons, P- value threshold at .05) between esti-
mations by different protocols.
3 |  RESULTS
Using the four models to fit in vivo data of different proto-
cols, whole brain and segmented GM CBF and ATT maps 
were obtained. Across all subjects, 1216 voxels were identi-
fied as having prolonged ATT (ATT > 1.8 s, 6.19% of all GM 
voxels), and 1268 voxels as having high macrovascular sig-
nal (aBV > 0.25%, 6.46% of all GM voxels). Representative 
whole- brain CBF and ATT estimation maps and absolute error 
maps (protocols − combined) from one subject are shown 
in Figure 1. Reasonably good visual agreement was found 
between different protocols and fitting models. Evidence of 
macrovascular contamination could be seen in some cortical 
voxels in reference multi- PLD and CBF- ATTopt, which ap-
peared as higher CBF estimation. CBFopt appeared to be in 
best agreement with the CBF estimation from the combined 
data among the three multi- PLD protocols.
Figure 2 shows CBF estimation errors for the different 
protocols with and without macrovascular contamination 





CBFRef - multi, gkm − CBFcombined, gkm+mvc
CBFcombined, gkm+mvc
× 100
F I G U R E  1  Representative whole- brain CBF and ATT estimation maps and absolute error maps (protocols − combined) for the four protocols 
tested and combined data estimates (by column), and for the four estimation models (by row). The maps show one axial slice from a single subject. 
A, CBF estimation map. B, ATT estimation map. C, CBF absolute error map. D, ATT absolute error map
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The general trends were consistent between simulation and 
in vivo data. All three multi- PLD protocols performed well 
within a normal range of ATT (ATT < 1.8 s), with only Ref 
Multi- PLD protocol exhibiting substantial error from macro-
vascular contamination within that range. In the absence of 
MVC, multi- PLD protocols could retain CBF accuracy be-
yond an ATT of 2.0 s up to 2.5 s for CBFopt (Figure 2A,C). 
No protocol had a consistently better performance than oth-
ers when macrovascular contamination was present over the 
wider ATT range (Figure 2B,D). ATT estimation errors of 
the three multi- PLD protocols under the same conditions are 
shown in Supporting Information Figure S2. ATT was un-
derestimated by all three protocols both in simulation and in 
vivo when ATT was prolonged. Despite having higher ATT 
estimation errors at short ATTs, CBFopt had the lowest ATT 
errors among all protocols at prolonged ATTs.
Figure 3 shows CBF and ATT estimation errors over a 
range of aBV both in simulation and in vivo using gkm and 
gkm+mvc as fitting models. The bar chart in Figure 4 shows 
the sensitivity values to macrovascular contamination, 
measured by the slope of error against aBV. When aBV 
was varied, all three multi- PLD protocols were sensitive to 
macrovascular contamination when fitted with gkm, over-
estimating CBF and underestimating ATT (see dashed lines 
in Figure 3A,B and star marks in Figure 3C,D). For CBF 
estimation in simulation, CBFopt had the smallest sensitiv-
ity value to macrovascular contamination (33.47% error per 
1% aBV) among multi- PLD protocols using gkm. For ATT 
estimation, the three multi- PLD protocols all significantly 
underestimated ATT, but were not significantly different 
from each other. Despite having different ground truth CBF 
values from simulation, similar relations were seen using in 
vivo data, where CBF sensitivity to macrovascular contam-
ination of CBFopt (60.21% error per 1% aBV) was much 
smaller than the reference multi- PLD (88.73% error per 1% 
aBV) and CBF- ATTopt (96.5% error per 1% aBV). By fit-
ting the signal with an extended kinetic model gkm+mvc, 
all multi- PLD protocols showed a notable decrease in CBF 
and ATT estimation error in simulation (solid lines in 
Figure 3A,B) and in vivo (triangle marks in Figure 3C,D). 
F I G U R E  2  CBF estimation mean errors for the four protocols fit with gkm. A, Simulation data using D- M- . B, Simulation data using D- M+, 
with aBV = 0.2%. C, In vivo estimation error with respect to CBFcombined, gkm. D, In vivo estimation error with respect to CBFcombined, gkm+mvc. The 
dashed magenta line indicates the upper limit of the range of ATT that CBF- ATTopt and CBFopt were optimized for
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Absolute CBF and ATT sensitivity values to macrovascu-
lar contamination were all lowered except for the absolute 
ATT sensitivity for the reference multi- PLD protocol with 
in vivo data (Figure 4).
When the degree of dispersion was varied in D+M- sig-
nals in simulation but not accounted for in the model fitting, 
as shown in Figure 5, both CBF and ATT were overestimated 
at shorter ATT and CBF was underestimated at prolonged 
ATT by all protocols. The CBF and ATT overestimation er-
rors increased with a higher degree of dispersion, with the 
highest increase by CBFopt being 7.82% and 15.23% in CBF 
estimation and 29.07% and 73.42% in ATT estimation when 
s = s0∕2 and s = s0∕4, respectively. The largest error of CBF 
underestimations all reached nearly −100% at the longest 
ATT, when the protocols could hardly detect meaningful 
signals due to the prolonged arrival time. When dispersion 
was accounted for in the model fitting by gkm+disp, which 
is shown in Supporting Information Figure S3, reference 
multi- PLD could retain CBF estimation accuracy up to 2.0 
s, while optimized protocols up to 2.5 s. ATT estimation er-
rors were significantly reduced when ATT < 1.8 s. Beyond 
the ATT range of 2.5 s, however, the three protocols did 
not show consistent increase or reduction of CBF and ATT 
errors.
4 |  DISCUSSION
In this work, we have explored the performance of several 
ASL imaging protocols in CBF and ATT estimation under 
the effects of macrovascular signal contamination, flow dis-
persion, and prolonged ATT.
F I G U R E  3  CBF and ATT estimation errors for the four protocols fitted with gkm and gkm+mvc over a range of aBV values. ATT was held 
constant at 1.4 s in simulation across all aBVs. A, CBF errors of simulation data on D- M+ signals. B, ATT errors of simulation data on D- M+ 
signals. C, CBF errors of in vivo data. D, ATT errors of in vivo data. In vivo estimation errors were calculated with respect to CBFcombined, gkm+mvc 
and ATTcombined, gkm+mvc. The star and triangle markers in (C) and (D) represent the mean errors at each binned value of aBV fit by gkm and 
gkm+mvc, respectively, while the dashed and solid lines represent the linear fit of errors when aBV > 0.5% by gkm and gkm+mvc, respectively
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F I G U R E  4  A- D, CBF and ATT sensitivity (unit: % error per 1% aBV) to macrovascular contamination for the four protocols with conditions 
in Figure 3. Sensitivity values represent the slopes of the lines of best fit when aBV > 0.5%
F I G U R E  5  CBF and ATT estimation fitted with gkm over a PAR on D+M- signals with different degrees of dispersion. A,D, s = s
0
, low 
degree of dispersion. B,E, s = s
0
∕2, moderate degree of dispersion. C,F,: s = s
0
∕4, high degree of dispersion. The dashed magenta line indicates the 
upper limit of the range of ATT that CBF- ATTopt and CBFopt were optimized for
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4.1 | Macrovascular contamination
The single PLD value recommended by the ASL consensus 
paper3 and tested in this study is 1800 ms, a trade- off between 
incomplete arrival of blood to the tissue voxels and a loss of 
ASL signal due to T1 relaxation. If the PLD is too short, part of 
the labeled blood may remain in the macrovasculature, lead-
ing to false interpretation of tissue perfusion by macrovas-
cular signals. This is particularly problematic in multi- PLD 
ASL, since short PLDs are often used to capture the arrival 
time information. When macrovascular contamination was 
included (Figure 3), CBF was overestimated and ATT was 
underestimated across all protocols at high aBV when using 
gkm, that is, not accounting for macrovascular contamination 
in the analysis. CBFopt had the least sensitivity to MVC of 
the multi- PLD protocols when gkm was used for analysis, as 
indicated by the smallest slope value against an increasing 
aBV, most probably because it mainly includes long PLDs 
within the sampling schedule. The three multi- PLD protocols 
yielded similar but high ATT estimation errors, significantly 
underestimating the ATT when no macrovascular compart-
ment was included in the model. This would be consistent 
with the model treating the macrovascular signal as tissue 
perfusion with a shorter ATT. When the extended model 
gkm+mvc was used, that is, the analysis explicitly attempted 
to correct for macrovascular contamination, all protocols 
showed a large improvement in CBF and ATT estimation. 
This was seen by a decrease of almost all CBF and ATT sen-
sitivity values by multi- PLD protocols using gkm+mvc than 
the original gkm in Figure 4. CBF- ATTopt showed signifi-
cantly lower error in estimating arterial blood volume than 
Reference multi- PLD and CBFopt using gkm+mvc, shown 
by Supporting Information Figure S4. This benefit could be 
due to the short ATTs within the CBF- ATTopt protocol.
When MVC was present in a PAR, shown in Figure 2B 
and Figure S2B, no protocol exhibited consistently better 
performance than others in CBF and ATT estimation. It is 
worth noting that, because flow crusher gradients were used 
to eliminate most of the macrovascular signal in the in vivo 
data, estimation errors with respect to CBFcombined, gkm+mvc 
(Figure 2D, Figure S2D) was not the in vivo equivalent of es-
timation using simulated D- M+ signals. A more direct com-
parison would be to use gkm+mvc to fit D- M- signals, which 
is presented in Supporting Information Figure S5. For both 
CBF and ATT estimation, fitting with gkm+mvc led to higher 
errors when ATT < 1.3 s, while the errors remained compa-
rable to fitting with gkm when ATT > 1.3 s, with CBFopt 
achieving smaller estimation SD. This, together with the fact 
that the in vivo results using CBFcombined, gkm+mvc in error 
calculation were not substantially different from the results 
using CBFcombined, gkm (Figure 2D,C), suggests that explicitly 
including a macrovascular compartment in the model used 
for analysis could be a successful strategy for controling for 
MVC, without necessarily having the knowledge of whether 
or not MVC was present.
The in vivo data used in this study included flow crusher 
gradients, as the study from which the data originated sought 
to test protocols without any macrovascular signal.7 Bipolar 
flow crusher gradients can be used to eliminate flowing la-
beled spins in one direction above a cutoff velocity. However, 
the macrovascular signals perpendicular to the gradient di-
rection are unaffected and present in the image. Thus, in prac-
tice, macrovascular contamination remains, as has been seen 
previously,8 and has been exploited here to examine the sen-
sitivity to macrovascular contamination. In general, the ASL 
white paper discouraged the use of flow crusher gradients,3 
concerning that important clinical information might be re-
moved, but leading to more prominent macrovascular signal 
contamination. Therefore, we would recommend the use of 
the two- compartment model in multi- PLD acquisitions to 
control, as well as potentially estimate for, the effect of MVC.
4.2 | Dispersion effects
We investigated the effects of flow dispersion by varying the 
sharpness parameter s in the Gamma kernel to control the de-
gree of dispersion. All protocols showed overestimation of 
CBF and ATT at short ATT and underestimation of CBF and 
ATT at prolonged ATT. This CBF overestimation is contrary 
to previous pulsed- ASL findings,9,16,17 in which dispersion 
effects were reported to cause an underestimation of CBF. A 
possible explanation is that, while the dispersion kernel atten-
uates the peak of the signal curve, the protocols examined in 
this study were mainly sampling the trailing edge of the curve 
when ATT was short, where dispersion increases the signal 
magnitudes compared to the non- dispersed case using the dis-
persion model implemented here. Across the three dispersion 
parameters tested, s = s0∕4 generated the greatest dispersion 
which in turn led to the highest error of CBF and ATT over-
estimation at short ATT, shown by Figure 5C,F. However, the 
bias due to dispersion was pretty consistent between different 
protocols. This suggests that, while flow dispersion does in-
fluence CBF and ATT estimation, the presence of dispersion 
would not alter the appropriateness of the existing optimal 
sampling framework, and our choice of an optimal protocol 
per se would not lead to particular egregious errors.
In this study, we chose a Gamma- shaped dispersion ker-
nel, which has a relative advantage in physiological plausibil-
ity and computational simplicity.12 Other shapes of dispersion 
kernels or vascular transport functions (VTFs) have also been 
proposed, such as the Gaussian kernel16,18 and the delay- 
dependent exponential kernel used in dynamic susceptibility 
contrast (DSC) imaging.19 Furthermore, there is debate as to 
whether one dispersion kernel independent to spatial loca-
tion could accurately describe the profile of flow dispersion 
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within every voxel. For instance, the macrovascular compo-
nent was seen to show a higher sensitivity to the choice of 
dispersion kernel than the tissue component.12 Future work 
could look into the effects of having different levels of dis-
persion between tissue and macrovascular compartments. In 
addition, the effects of dispersion could be controlled by de-
termining an AIF that is upstream to the voxel, that is, a local 
AIF. Methods, such as subtraction of signals with and with-
out flow crusher gradients20 or using independent component 
analysis,21 have been developed to obtain a local AIF, thus 
reducing the errors arising from dispersion effects.
4.3 | Prolonged ATT
The ATT range used in the optimization of CBF- ATTopt and 
CBFopt was [0.5 s, 1.8 s]. In this study, we tested the per-
formance of the protocols with an extended ATT range [0.5 
s, 3.0 s] to reflect potential unexpected deviations from this 
narrow range in practice, although for application in cohorts 
where longer ATTs are expected, the optimization range 
should be adjusted (eg, see Woods et al7 and Supporting 
Information Table S1).
For CBF estimation, all four protocols underestimated 
CBF at prolonged ATT, as expected. We could see from 
Figure 2 that the single- PLD protocol was much more sen-
sitive to the change of tissue ATT than the multi- PLD pro-
tocols in the normal ATT range. Although the consensus 
paper recommended the use of a 1800 ms single- PLD pro-
tocol for young and healthy adults, and 2000 ms single- PLD 
for elderly subjects or pathological conditions,3 our results 
showed a worse performance of the single- PLD protocol than 
multi- PLD protocols under the tested SNR. In keeping with 
the study of Woods et al,7 the estimation by the optimized 
multi- PLD protocols, CBF- ATTopt and CBFopt, was quite 
satisfactory until tissue ATT was out of their initial optimized 
range. CBFopt and CBF- ATTopt remained reasonably accu-
rate up to ATT = 2.5 s for CBF and ATT estimation, respec-
tively (Figure 2A and Supporting Information Figure S2A). 
The standard deviations of CBF and ATT estimation errors in 
simulation are shown in Supporting Information Figure S6. 
Estimation SDs by gkm+mvc were significantly smaller than 
those by gkm in the PAR. This might be because the presence 
of the extra signal from the macrovascular component gives 
a higher SNR, leading to a more consistent parameter fitting. 
In the in vivo results, CBFopt had significantly lower abso-
lute errors in CBF estimation than all other protocols in the 
extended ATT range, whether the errors were calculated with 
respect to CBFcombined, gkm or CBFcombined, gkm+mvc (average re-
duction of 4.96% or 9.45% CBF estimation error compared 
to CBF- ATTopt, respectively), and without having signif-
icant differences in ATT errors compared to CBF- ATTopt. 
In accordance with the lowest sensitivity value to MVC of 
CBFopt; therefore, we argue that CBFopt is the least sensitive 
protocol to MVC and unexpectedly prolonged ATT for CBF 
estimation, while maintaining reasonably good performance 
in estimating ATT. We may further conclude that the opti-
mization framework can still be used where some prolonged 
ATTs (up to 2.5 s) might be expected, particularly where the 
majority of the voxels are likely to fall within the optimal 
range. Beyond this ATT range, the protocols would become 
overly sensitive to the long ATTs, and the optimization range 
should be reconsidered.
4.4 | Results from 3D- readout protocols
To investigate further the effects of using a protocol outside 
of its optimized range, more simulations were performed 
using the optimal protocols designed for segmented 3D- 
readout,7 which are listed in Supporting Information Table 
S2. These two sets of protocols were optimized for a normal 
ATT range (NAR) [0.5 s, 2.0 s] and a PAR [1.0 s, 3.0 s], and 
were both tested under the same simulation conditions across 
the aBV range [0.0, 2.0%] and the ATT range [0.5 s, 3.0 s] as 
the 2D- readout case.
CBF and ATT estimation errors across the aBV range can 
be found in Supporting information Figure S7. PAR protocols 
appeared to be more predictable than NAR protocols, giving 
near- linear sensitivity to aBV in both estimations when aBV 
> 1.25% (Supporting Information Figure S7B). Furthermore, 
PAR protocols produced more consistent results when using 
gkm+mvc, clearly reducing the estimation error, whereas in 
NAR protocols the results were more variable. CBF and ATT 
estimation errors across the PAR can be found in Supporting 
Information Figure S8. Within the overlapping ATT range of 
[1.0 s, 2.0 s], there were similar CBF and ATT estimation errors 
between NAR and PAR versions of CBF- ATTopt and CBFopt. 
However, NAR protocols had a consistently lower standard de-
viation than PAR protocols for CBF- ATTopt and CBFopt in 
this range. Expectedly, NAR protocols had better performance 
when ATT < 1.0 s, while PAR protocols did better when ATT 
> 2.0 s. This indicates that optimized protocols would evi-
dently yield higher accuracy within their optimized range, but 
could only work sub- optimally outside this range. Choosing the 
appropriate optimized protocol, thus, is critical in controlling 
estimation errors. In the meantime, if prior knowledge of the 
ATT profile of the dataset is provided, a non- uniform ATT dis-
tribution can be used in the optimization process to give differ-
ent weights to the ATTs within the optimized range.
4.5 | Limitations
This study has a few limitations. First, the results are 
based on the estimation from the extended kinetic model 
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that assumes a specific shape of dispersion kernel and 
macrovascular AIF. Meanwhile, other artifacts might also 
be present in real data, further confounding the accurate 
quantification of perfusion and ATT. For example, T2* dif-
ferences between capillary and tissue might cause an un-
derestimation of CBF using the one- compartment model; 
partial volume effects in which different composites of the 
brain tissue share the same voxel will underestimate perfu-
sion in the gray matter and overestimate perfusion in the 
white matter. Second, assumptions have been made at vari-
ous stages in simulation that might be violated in vivo. For 
example, the difference between bolus arrival times of the 
macrovascular signal and the tissue signal is assumed to 
remain a constant of 0.5 s in this study. Further research 
is needed to investigate how this assumption might affect 
the outcome. It is also worth noting that the improvement 
of CBF estimation seen in simulated data using gkm+mvc 
should not be over- interpreted as implying that the observed 
benefit will necessarily be achieved in real data since these 
are idealized experiments in which the same model is used 
to fit the model- generated data.
Third, the optimized protocols so far have only been ap-
plied to a young and healthy population, who typically have 
the ATTs in the optimized range. This work did preliminary 
analyses on a small dataset that included limited voxels that 
had prolonged ATT. Future work could explicitly focus on 
elderly or pathological groups, investigate the effects of these 
protocols on long ATTs, and compare them to appropriately 
optimized protocols for these groups. This could help estab-
lish the importance of protocol optimization for each sub- 
population due to their varying ATT ranges.
5 |  CONCLUSIONS
In conclusion, we have examined four ASL protocols under 
the effects of dispersion and macrovascular contamination 
over a PAR. Explicitly including a macrovascular component 
in the kinetic model was shown to be a feasible approach in 
controlling for MVC. Furthermore, we argue that, among all 
protocols, CBFopt was the least sensitive protocol to MVC 
and unexpectedly prolonged ATT for CBF estimation while 
maintaining reasonably good performance in estimating 
ATT.
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SUPPORTING INFORMATION
Additional Supporting Information may be found online in 
the Supporting Information section.
FIGURE S1 The effect of different dispersion kernels to the 
tissue (solid lines) and macrovascular signals (dashed lines). 
A smaller parameter s indicates a higher level of flow disper-
sion. Parameters used in this simulation: tissue ATT = 1.4s, 
macrovascular ATT = 0.9s
FIGURE S2 ATT estimation errors for the 3 multi- PLD pro-
tocols fitted with gkm over a prolonged ATT range. (A): simu-
lation data using D- M- ; (B): simulation data using D- M+; (C): 
in vivo estimation error with respect to ATTcombined, gkm; (D): 
in vivo estimation error with respect to ATTcombined, gkm+mvc. 
The dashed magenta line indicates the upper limit of the range 
of ATT that CBF- ATTopt and CBFopt was optimised for
FIGURE S3 Simulation CBF and ATT estimation errors for 
the 4 protocols fit with gkm or gkm+disp using D+M- sig-
nals (kernel sharpness s = s0) over a prolonged ATT range. 
(A): CBF errors fit with gkm; (B): CBF errors fit with gk-
m+disp; (C): ATT errors fit with gkm; (D): ATT errors fit 
with gkm+disp
FIGURE S4 Arterial blood volume (aBV) estimation means 
and standard deviations for the 3 multi- PLD protocols fitted 
with gkm+mvc using D- M+ signals. The dashed magenta 
line indicates identity
FIGURE S5 Simulation CBF and ATT estimation error 
means and standard deviations for the 4 protocols fitted with 
gkm or gkm+mvc using D- M- signals over a prolonged ATT 
range
FIGURE S6 Simulation CBF and ATT estimation error stan-
dard deviations for the 4 protocols fitted with gkm over a 
prolonged ATT range. (A): CBF error std using D- M- ; (B): 
CBF error std using D- M+; (C): ATT error std using D- M- ; 
(D): ATT error std using D- M+. The dashed magenta line in-
dicates the upper limit of the range of ATT that CBF- ATTopt 
and CBFopt was optimised for
FIGURE S7 Simulation CBF and ATT estimation errors for 
the 3 normal- range protocols and 3 prolonged- range protocols 
fit with gkm over a range of aBV using D- M+ signals. ATT 
was held constant at 1.4s in simulation across all aBVs. (A): 
CBF errors of normal- range protocols; (B): CBF errors of 
prolonged- range protocols; (C) ATT errors of normal- range 
protocols; (D): ATT errors of prolonged- range protocols
FIGURE S8 Simulation CBF and ATT estimation error 
means and standard deviations for the 3 normal- ATT- range 
(NAR) protocols and 3 prolonged- ATT- range (PAR) proto-
cols fitted with gkm over a prolonged ATT range using D- M- 
signals. (A): CBF errors of NAR protocols; (B): CBF errors 
of PAR protocols; (C) CBF errors std of NAR & PAR proto-
cols; (D) ATT errors of NAR protocols; (E): ATT errors of 
PAR protocols; (F): ATT errors std of NAR & PAR protocols
TABLE S1 Specifications of the estimation priors (as mean 
and standard deviation by a normal distribution) used in 
the variational Bayesian inference method for simulation 
experiments
TABLE S2 Protocol timings of 3D readout from Woods 
et al7. Two sets of protocols were developed, one for a nor-
mal range of 0.5 ≤ ATT ≤ 2.0 s, the other one for a prolonged 
range of 1.0 ≤ ATT ≤ 3.0 s
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